🧠 At a Glance
Hestia Insight Inc., a mysterious Las Vegas–based microcap, just released its latest quarterly financial update. And it’s one for the ages.
- 💸 Revenue: $0
- 📉 Net Loss: $289,837
- 🧾 Cash Left: $3,255
- 🧪 Business Model: Still under construction… since 2021
- 🧙♂️ Survival Plan: Issue more shares and hope someone invests
Yes, it’s one of those companies. The kind that exist only to file updates and dilute shareholders. Welcome to the Wild West of American microcaps.
🧬 What Even Is Hestia Insight?
Let’s let them speak for themselves:
“Hestia is a strategic investment and development firm focused on healthcare and biotech.”
Translation:
“We don’t make anything. We don’t sell anything. But we might one day buy something that does.”
The company operates through a wholly owned subsidiary called Hestia Investments Inc., which… also doesn’t do anything yet.
Their only recent activity? Signing vague LOIs (Letters of Intent) and telling investors they “may evaluate several health-related assets” in the future.
It’s basically Shark Tank — if the sharks were broke and the tank was filled with debt.
💰 Financials: A Glorious Nothingburger
| Metric | Mar 2024 | Mar 2025 |
|---|---|---|
| Revenue | $0 | $0 |
| Operating Expenses | $203,500 | $289,837 |
| Net Loss | ($203,500) | ($289,837) |
| Cash | $7,264 | $3,255 |
| Total Assets | $297,873 | $205,164 |
| Total Liabilities | $1.35 million | $1.56 million |
| Working Capital | Negative | Deeply Negative |
Hestia has officially entered the “we need money to keep filing that we need money” stage.
🔍 Red Flags? Oh, We’ve Got a Few
- Revenue = ₹0. Not “flat.” Not “declining.” Literally zero.
- Accumulated deficit now exceeds $16 million.
- No ongoing operations, no commercial product, no customers.
- They’ve defaulted on promissory notes in the past.
- The only “asset” is a vague intent to maybe do something someday.
- Their “plan” to survive? Issue more stock, hope someone buys.
Let’s not sugarcoat it:
Hestia is a publicly traded PDF generator with a cap table.
🧪 “Strategic Vision”: The Vaporware
They claim to be “actively searching” for healthcare investments — like medical data firms, wellness tech, and biotech tools. But for the third year in a row, there’s no M&A, no deal closures, and no IP added.
Instead, they:
- Reorganized corporate structures
- Renamed internal shells
- Filed SEC reports with updated logos
It’s like watching someone rearrange deck chairs on a cruise ship that hasn’t even left the dock.
📉 Stock Performance (and Why It’s Down Bad)
- Ticker: HSTA (OTC Markets)
- Last traded price: ~$0.007
- Market Cap: Around $350K
- Outstanding Shares: Exploding quarterly
This isn’t just a penny stock. It’s a fraction-of-a-penny stock.
And they keep issuing more shares to pay bills. Every investor is getting diluted faster than homeopathy in a swimming pool.
🧠 EduInvesting Take
Let’s be blunt.
Hestia Insight Inc. is not a healthcare company. It’s a PowerPoint idea in search of a business.
There are no operations. No tech. No revenue. Just management salaries, vague investor promises, and a deep belief that if you file enough times, someone will believe in you.
“Hope is not a strategy” — except on the OTC market.
🚨 TL;DR
| 🔥 Fact | 💥 Reality |
|---|---|
| Revenue | $0 for 2+ years |
| Cash | $3,255 |
| Net Loss This Quarter | $289K |
| Real Business? | ❌ |
| Main Activity | Filing updates, issuing stock |
| Edu Verdict | “Startup” in theory, slow-motion dilution in practice |
This is not a growth company. This is a business costume.
Unless they buy something soon — or pivot into AI toothbrushes or NFTs for wellness — Hestia might soon be known as:
“That one OTC company that kept filing right up to bankruptcy.”
Author: Prashant Marathe
Date: June 4, 2025
Tags: Hestia Insight, OTC stocks, zero revenue companies, financial red flags, microcap warning, stock dilution
